Walied Alarif | Nanomaterials | Editorial Board Member

Published on by Research Awards

Prof Dr. Walied Alarif | Nanomaterials | Editorial Board Member 

Department of Marine Chemistry, Faculty of Marine sciences, King Abdulaziz University | Saudi Arabia

Prof. Walied Mohamed Alarif is a distinguished Egyptian scholar and leading expert in Marine Organic Chemistry and Natural Products, with a career spanning more than two decades across research, academia, analytical chemistry, and marine bioactive substance discovery. Born on July 1, 1973, Prof. Alarif earned his B.Sc. in Chemistry (1995), M.Sc. in Organic Chemistry (1999), and Ph.D. in Organic Natural Products Chemistry (2005) from Mansoura University, Egypt. His scientific specialization centers on marine natural products, environmental chemistry, spectroscopy, and bioactive metabolites from marine organisms, particularly those inhabiting the Red Sea ecosystem. His early career began at Mansoura University as an instructor and research assistant (1996–2000), followed by significant research roles in forensic chemistry at the Egyptian Ministry of Justice from 2000 to 2007. He later joined King Abdulaziz University (KAU), Saudi Arabia, where he advanced from Assistant Professor in 2007 to Associate Professor in 2013, and ultimately to Professor of Marine Organic Natural Products in May 2018 in the Marine Chemistry Department, Faculty of Marine Sciences. Prof. Alarif has demonstrated strong leadership through numerous administrative roles at KAU, including Chairman of the Academic Accreditation Committee for the Ph.D. program, Self-Study Coordinator for the B.Sc. program, Academic Advisor for postgraduate studies, and long-term member of key committees such as Academic Affairs and Quality Committees (2014–2024). His research from 2020–2024 focuses on bioactive metabolites from Red Sea soft corals, discovery of novel biologically active compounds from Saudi marine organisms, and nano-sized antifouling preparations from marine environments. He has led major funded research projects including G:173-150-1441, G:450-150-1442, and IFPRC-134-150-2020. Prof. Alarif has also contributed to scientific training globally, including specialized training on Thermo Finnigan LTQ MS/MS mass spectrometry systems in New York, USA. His international impact is reflected in keynote speaking engagements, such as at the International Conference on Pharmaceutical Material, Engineering and Applied Science (ICOPMES 2020) in Indonesia. Prof. Alarif holds notable patents, including a pharmaceutical anticancer composition (US Patent 10,292,972B1) and marine natural product-based TiO₂ nanoparticles for eco-friendly antifouling (2022). His scholarly contributions include numerous publications in journals such as Journal of Saudi Chemical Society, Latinoamericana de Química, Biochemical Systematics and Ecology, CLEAN – Soil, Air, Water, Chemical and Pharmaceutical Bulletin, European Journal of Medicinal Chemistry, and more. With a strong publication record, Scopus ID 36157750600, and Web of Science Researcher ID H-7549-2012, Prof. Alarif continues to advance the frontiers of marine natural product chemistry, contributing significantly to drug discovery, marine ecology, and environmental sustainability.

Profile: Scopus | Orcid

Featured Publications

Dawidar, A. M., Ayyad, S. N., Abdel-Mogib, M., & Alarif, W. M. (2005). Humulene sesquiterpene lactone from Asteriscus schimperi. Journal of Saudi Chemical Society, 9(1), 137–142.

 Ayyad, S. N., Hoye, R. T., Dawidar, A. M., Abdel-Mogib, M., & Alarif, W. M. (2007). Constituents of Melia azedarach L. Revista Latinoamericana de Química, 36(1), 7–12.

Al-lihaibi, S. S., Ayyad, S. N., Al-wessaby, E., & Alarif, W. M. (2010). Dihydroxy-Δ-cholestan-11-one: A new oxidation pattern of cholestane skeleton from Laurencia papillosa. Biochemical Systematics and Ecology, 38, 861–863.

Alarif, W. M., Ayyad, S. N., & Al-lihaibi, S. S. (2010). Acyclic diterpenoid from the red alga Gracilaria foliifera. Revista Latinoamericana de Química, 38(3), 52–58.

Alarif, W. M., Abou-Elnaga, Z. S., Ayyad, S. N., & Al-lihaibi, S. S. (2010). Insecticidal metabolites from the green alga Caulerpa racemosa. CLEAN – Soil, Air, Water, 38, 548–557.

Al-lihaibi, S. S., Ayyad, S. N., Shaher, F. M., & Alarif, W. M. (2010). Antibacterial sphingolipid and steroids from the black coral Antipathes dichotoma. Chemical and Pharmaceutical Bulletin, 58(11), 1635–1638.

Ayyad, S. N., Makki, M. S., Al-kayal, N. S., Basaif, S. A., El-Foty, K. O., Asiri, A. M., Alarif, W. M., & Badria, F. A. (2011). Cytotoxic and protective DNA damage of three new diterpenoids from the brown alga Dictoyota dichotoma. European Journal of Medicinal Chemistry, 46, 175–182.

Ayyad, S. N., Al-Footy, K. O., Alarif, W. M., Sobahi, T. R., Basaif, S. A., Makki, M. S., Asiri, A. M., Al Halwani, A. Y., Badria, A. F., & Badria, F. A. (2011). Bioactive C15 acetogenins from red alga Laurencia obtusa. Chemical and Pharmaceutical Bulletin, 59(10), 1294–1298.

Xiaoying Yin | Nanocomposite Development | Best Researcher Award | 13546

Published on by Research Awards

Prof Dr. Xiaoying Yin | Nanocomposite Development | Best Researcher Award 

Prof Dr. Xiaoying Yin, Shanghai University of Engineering Science, China

Prof. Dr. Xiaoying Yin, a distinguished Professor and Doctoral Supervisor at the Shanghai University of Engineering Science, is a leading expert in biomaterials science and traditional Chinese medicine-based drug discovery. Holding a Ph.D. from China Pharmaceutical University, she has made substantial contributions to nanocomposite material development and active ingredient screening. She has led multiple National Natural Science Foundation projects, published over 100 scientific papers, and holds 18 patent applications, including international grants. A recipient of numerous provincial and national innovation awards, Prof. Yin also holds esteemed positions in various professional committees advancing pharmaceutical modernization and clinical translation in China.

Author Profile

Scopus

Prof. Dr. Xiaoying Yin embarked on her academic journey with a deep passion for pharmaceutical sciences and biomedical innovation. She earned her Ph.D. from China Pharmaceutical University, one of the nation’s most prestigious institutions in drug development and pharmacology. Her early research reflected a strong inclination toward traditional Chinese medicine (TCM) and advanced chemical engineering, laying a solid foundation for her future interdisciplinary work. Her academic pursuits during her formative years not only shaped her scientific thinking but also ignited her lifelong interest in integrating modern materials science with traditional therapeutic principles.

Experience

Currently serving as a Level 3 Professor and Doctoral Supervisor at the School of Chemistry and Chemical Engineering / Institute for Frontier Medical Technology, Shanghai University of Engineering Science, Prof. Yin is recognized as a pillar in both academia and applied research. Her leadership extends beyond teaching, into pioneering research in biomaterials, nanocomposites, and drug discovery from TCM.

She has also enriched her global perspective through academic exchange as a Senior Visiting Scholar at the School of Pharmaceutical Sciences, Peking University, broadening her network and influence in national-level pharmaceutical sciences.

In addition to her institutional roles, she holds multiple influential appointments, including:

  • Standing Committee Member, Chinese Medicine Analysis Branch of the China Association of Chinese Medicine 🧪

  • Council Member, Health Industry Branch, China Association of National Medicine 🏥

  • Standing Professional Committee Member, Clinical Translation of Pharmaceutical Modernization 🧬

Research Focus

Prof. Yin has consistently contributed to the advancement of biomaterials science, nanocomposite material development, and the screening and identification of active compounds in traditional Chinese medicine. Her research is characterized by a unique blend of traditional knowledge and modern scientific methods, which she leverages to identify lead compounds with potential therapeutic applications.

🔬 Over the years, she has:

  • Led four major projects funded by the National Natural Science Foundation of China (NSFC)

  • Participated in three national key science and technology support programs

  • Directed over 10 provincial/ministerial-level research projects

She has authored 100+ academic publications, including 60+ SCI and EI-indexed journal papers. Her extensive research portfolio demonstrates both the depth and breadth of her contributions to pharmaceutical sciences.

Award and Recognition

Prof. Yin’s outstanding work has been recognized through numerous awards and honors:

  • Provincial Natural Science Award (Second Prize) 🏅

  • Two Provincial Science and Technology Progress Awards 🔬

  • Innovation Achievement Awards from national-level academic associations

  • Second and Third Prize for Innovation in Higher Education Institutions 🎓

In addition to publishing extensively, she has:

  • Applied for 18 domestic and international invention patents, including 2 PCT patents

  • Received 11 granted patents, including 2 international patents approved in the UK and other countries

Publications

📘Molecular Mechanisms of Reversal of Multidrug Resistance in Breast Cancer by Inhibition of P-gp by Cytisine N-Isoflavones Derivatives Explored Through Network Pharmacology, Molecular Docking, and Molecular Dynamics – International Journal of Molecular Sciences(2025).

📘Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation – Molecular Informatics(2024).

📘Kinase-Bench: Comprehensive Benchmarking Tools and Guidance for Achieving Selectivity in Kinase Drug Discovery – Journal of Chemical Information and Modeling(2024).

📘Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia – Biomedicine and Pharmacotherapy(2023).